It is estimated that 75% of vision loss is preventable(1); 1 in 9 patients develop irreversible vision loss by age 65, and 1 in 4 do so by age 75.Pharmacists are ideally positioned to educate patients about controllable risk factors for eye disease and help them select products formulated to meet their unique needs.
It is estimated that 75% of vision loss is preventable(1); 1 in 9 patients develop irreversible vision loss by age 65, and 1 in 4 do so by age 75.Pharmacists are ideally positioned to educate patients about controllable risk factors for eye disease and help them select products formulated to meet their unique needs.
It is estimated that 75% of vision loss is preventable(1); 1 in 9 patients develop irreversible vision loss by age 65, and 1 in 4 do so by age 75.Pharmacists are ideally positioned to educate patients about controllable risk factors for eye disease and help them select products formulated to meet their unique needs.
Comparative Study of the Efficacy and Tolerability of Dihydroartemisinin-piperaquine-trimethoprim Versus Artemether-lumefantrine in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Cameroon,